International Immunology, Vol. 13, No. 5, 657-664,
May 2001
© 2001 Japanese Society for Immunology
A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation
1 Departments of Immunology and
2 Medicine, Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
3 Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA
Correspondence to: V. M. Holers, Division of Rheumatology, Box B-115, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
Expression of human complement receptor type 2 (CR2/CD21) is primarily restricted to mature B cells and follicular dendritic cells. We previously described an intronic transcriptional silencer that controls the appropriate B cell-specific and developmentally restricted expression of human CR2/CD21 in both stably transfected cell lines and transgenic mice. Here we report the identification of a nucleotide sequence within the 2.5 kb CR2 silencer (CRS) that is crucial to its silencer function. This site comprises a binding site for the transcriptional repressor CBF1 (RBP-J or RBP-J
) as well as Sp1 and other as yet uncharacterized proteins. A 2-bp mutation which eliminates the binding of CBF1 and other protein(s) in vitro results in loss of silencer activity in vivo. These results demonstrate the importance of this site in regulating CR2 expression and suggest that CBF1, a component of the developmentally important Notch signaling pathway, may play a role in the control of human CR2 gene expression.
Keywords: B lymphocytes, CBF1, cellular differentiation, complement, gene regulation, transcription factors
4 Present address: Department of Immunology, Box 357650, University of Washington, Seattle, WA 98195, USA
Transmitting editor: L. H. Glimcher
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Liu, J.-Y. Zhu, and Z.-X. Niu Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2 Clin. Vaccine Immunol., June 1, 2008; 15(6): 901 - 910. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wu, S. A. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. M. Grossman, Y. Lee, N. Shen, L. J. Abraham, T. R. Mercer, E. Park, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus PNAS, March 6, 2007; 104(10): 3961 - 3966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sironi, G. Menozzi, G. P. Comi, R. Cagliani, N. Bresolin, and U. Pozzoli Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences Hum. Mol. Genet., September 1, 2005; 14(17): 2533 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maier, M. Santak, A. Mantik, K. Grabusic, E. Kremmer, W. Hammerschmidt, and B. Kempkes A Somatic Knockout of CBF1 in a Human B-Cell Line Reveals that Induction of CD21 and CCR7 by EBNA-2 Is Strictly CBF1 Dependent and that Downregulation of Immunoglobulin M Is Partially CBF1 Independent J. Virol., July 15, 2005; 79(14): 8784 - 8792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-g. Hu, H. Illges, C. Gruss, and R. Knippers Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes Int. Immunol., June 1, 2005; 17(6): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chang, Y. Gwack, D. Kingston, J. Souvlis, X. Liang, R. E. Means, E. Cesarman, L. Hutt-Fletcher, and J. U. Jung Activation of CD21 and CD23 Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus RTA J. Virol., April 15, 2005; 79(8): 4651 - 4663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Esparza-Gordillo, E. G. d. Jorge, A. Buil, L. C. Berges, M. Lopez-Trascasa, P. Sanchez-Corral, and S. R. d. Cordoba Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 Hum. Mol. Genet., March 1, 2005; 14(5): 703 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ulgiati, C. Pham, and V. M. Holers Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms J. Immunol., June 15, 2002; 168(12): 6279 - 6285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ulgiati and V. M. Holers CR2/CD21 Proximal Promoter Activity Is Critically Dependent on a Cell Type-Specific Repressor J. Immunol., December 15, 2001; 167(12): 6912 - 6919. [Abstract] [Full Text] [PDF]
|
|